Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee (Q74509842)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572324%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

meta-analysis

0 references

title

Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572324%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

C J Hawkey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572324%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572324%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572324%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572324%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572324%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

67S-74S; discussion 79S-80S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572324%20AND%20SRC:MED&resulttype=core&format=json

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Epidemiological and financial aspects of the use of non-steroidal anti-inflammatory analgesics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Non-steroidal anti-inflammatory drugs and peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Nonsteroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Abolition by omeprazole of aspirin induced gastric mucosal injury in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Omeprazole ameliorates aspirin-induced gastroduodenal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900215-5

10.1016/S0002-9343(97)00215-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572324%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9572324%20AND%20SRC:MED&resulttype=core&format=json